Gamma-Linolenic Acid (GLA) |
|
|
Clinical Trial: Lactic Acid in the Rectum and Life-Threatening Infection.
This study is not yet open for patient recruitment.
Verified by Copenhagen University Hospital at Herlev September 2005
|
Purpose
Life-threatening infection impairs bloodflow to the gut, thereby causing less delivery of oxygen. This leads to increased formation of lactic acid.
We hypothesize, that the more serious the condition, the higher the concentration of lactic acid will be, thus relating to the risk of multiple organ failure or death.
| Condition | Intervention |
|---|---|
| Septic Shock | Procedure: Measurement of rectal lactic acid. |
MedlinePlus related topics: Sepsis
Study Type: Observational
Study Design: Natural History, Cross-Sectional, Defined Population, Prospective Study
Official Title: Does the Concentration of L-Lactate in the Rectum Correlate with Mortality and Morbidity in Patients with Septic Shock?
Expected Total Enrollment: 150
Study start: November 2005; Expected completion: December 2006
Last follow-up: December 2006; Data entry closure: December 2006
Eligibility
Inclusion Criteria:
- Fluid resuscitated septic shock < 24 h.
Exclusion Criteria:
- Septic shock > 24 h.
- Pathology in the rectum.
- Bleeding per rectum.
- Limitation of therapy
- Where informed consent from relatives cannot be obtained.
Location and Contact Information
Anders Perner, MD, PhD +45 44 88 38 39 ap@dadlnet.dk
Denmark
Dept. of Intensive Care, Herlev University Hospital, Herlev, DK-2730, Denmark
Dept. of Intensive Care, Glostrup University Hospital, Glostrup, DK-2600, Denmark
Dept. of Intensive Care, Gentofte University Hospital, Hellerup, DK-2900, Denmark
Dept. of Intensive Care 4131, Rigshospitalet, Copenhagen, DK-2100, Denmark
Finland
Dept. of Intensive Care, Tampere University Hospital, Tampere, 33521, Finland
Anders Perner, MD, PhD, Study Chair, Dept. of Anaesthesia and Intensive Care, Herlev University Hospital, DK-2730 Herlev
More Information
Last Updated: September 19, 2005
Record first received: September 14, 2005
ClinicalTrials.gov Identifier: NCT00197938
Health Authority: Denmark: The Regional Committee on Biomedical Research Ethics
ClinicalTrials.gov processed this record on 2005-09-20

Not Signed In -


